EUVIMEDEUVIMED entdecken
EditorialOpen Access

Navigating next-generation HR+/HER2− metastatic breast cancer therapies: a critical commentary on abemaciclib vs. tucidinostat after palbociclib progression

Patrick Neven, Lieke Dullens, Sileny Han, Anne Deblander, Yannick Van Herck, Maxime Van Houdt, Hans Wildiers

Translational Breast Cancer Research · 2023-10 · 4 · 31-31

DOI: 10.21037/tbcr-23-41 ↗

Kurz gefasst

Editorial in der Zeitschrift Translational Breast Cancer Research, 2023-10. Verfasst von Patrick Neven und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, KU Leuven-University of Leuven, Leuven, Belgium. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Metastatic breast cancer (MBC)abemaciclibcyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i)hormone receptor-positive (HR+)tucidinostat

Autor:innen und Institutionen

  • Department of Oncology, KU Leuven-University of Leuven, Leuven, Belgium.
  • Department of Gynaecological Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Master Student of Medicine, KU Leuven-University of Leuven, Leuven, Belgium.
  • Laboratory of Experimental Oncology, University Hospitals Leuven, Leuven, Belgium.

Zitieren

APA

Neven, P., Dullens, L., Han, S., Deblander, A., Van Herck, Y., Van Houdt, M., & Wildiers, H. (2023). Navigating next-generation HR+/HER2− metastatic breast cancer therapies: a critical commentary on abemaciclib vs. tucidinostat after palbociclib progression. Translational Breast Cancer Research, 4, 31-31. https://doi.org/10.21037/tbcr-23-41

Vancouver

Neven P, Dullens L, Han S, Deblander A, Van Herck Y, Van Houdt M, et al. Navigating next-generation HR+/HER2− metastatic breast cancer therapies: a critical commentary on abemaciclib vs. tucidinostat after palbociclib progression. Translational Breast Cancer Research. 2023;4:31-31. doi:10.21037/tbcr-23-41

BibTeX
@article{Neven2023,
  author = {Neven, Patrick and Dullens, Lieke and Han, Sileny and Deblander, Anne and Van Herck, Yannick and Van Houdt, Maxime and Wildiers, Hans},
  title = {Navigating next-generation HR+/HER2− metastatic breast cancer therapies: a critical commentary on abemaciclib vs. tucidinostat after palbociclib progression},
  journal = {Translational Breast Cancer Research},
  year = {2023},
  volume = {4},
  pages = {31--31},
  doi = {10.21037/tbcr-23-41}
}
Kostenlos starten →